Bjartell, Anders
Lumen, Nicolaas
Maroto, Pablo
Paiss, Thomas
Gomez-Veiga, Francisco
Birtle, Alison
Kramer, Gero
Kalinka, Ewa
Spaëth, Dominique
Feyerabend, Susan
Matveev, Vsevolod
Lefresne, Florence
Lukac, Martin
Wapenaar, Robert
Costa, Luis
Chowdhury, Simon
Funding for this research was provided by:
Janssen EMEA
Lund University
Article History
Accepted: 6 March 2021
First Online: 7 April 2021
Declarations
:
: This study was funded by Janssen EMEA. Janssen EMEA contributed to the study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication.
: Simon Chowdhury has participated in speaker bureaus and acted as a consultant for Johnson & Johnson, Astellas, Sanofi, and Clovis, and has received research grants from Clovis. Anders Bjartell has received remuneration from Janssen, Astellas, Sandoz, Ipsen, AstraZeneca, Merck, and Bayer for lectures and for participation in advisory boards, and from Ferring and Astellas for investigator-initiated trials. Nicolaas Lumen has participated in advisory boards for Astellas, Janssen, and Bayer, receives grants from Astellas, Janssen, Bayer, Sanofi, Ferring, and Ipsen, and receives speaker honoraria from Bayer, Astellas, Janssen, GSK, and Ipsen. Pablo Maroto has participated in advisory boards for Janssen, Astellas, and Bayer. Thomas Paiss reports no conflicts of interest. Francisco Gomez-Veiga has received remuneration from Bayer, Astellas, Janssen, and Amgen for lectures and for participation in advisory boards. Alison Birtle has participated in advisory boards and provided educational meeting support for Janssen, Astellas, Sanofi Genzyme, Bayer, and Roche. Gero Kramer reports no conflicts of interest. Ewa Kalinka has received honoraria from Janssen and Medivation/Pfizer. Dominique Spaëth reports no conflicts of interests. Susan Feyerabend reports no conflicts of interest. Vsevolod Matveev has participated in advisory boards for and received speaker honoraria from Astellas, Bayer, Janssen, and Sanofi. Florence Lefresne is an employee of Janssen Pharmaceutica N.V. and holds stock in Johnson & Johnson. Martin Lukac is an employee of Parexel International Czech Republic s.r.o, on behalf of Janssen Pharmaceutica N.V., Beerse, Belgium. Robert Wapenaar is an employee of Janssen-Cilag B.V. and holds stock in Johnson & Johnson. Luis Costa has participated in advisory boards for Janssen, Astellas, and Bayer, and has received speaker honoraria from Janssen and Bayer.
: The data-sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at ExternalRef removed. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at ExternalRef removed.
: AB was involved in data collection, contributed to data interpretation, participated as co-investigator, reviewed the manuscript, and had final responsibility for the decision to submit for publication. Simon Chowdhury was involved in data collection, contributed to data interpretation, and reviewed the manuscript. NL was involved in patient recruitment/data collection, data interpretation, and reviewing the manuscript. PM was involved in data collection and contributed to data analysis, interpretation, and review of the manuscript. TP was involved in data collection and contributed to review of manuscript drafts. FG-V was involved in data collection, contributed to data interpretation, reviewed the manuscript, and participated as co-investigator in the PCR. AB was involved in data collection and contributed to review of manuscript drafts. GK was involved in data collection and contributed to review of manuscript drafts. EK was involved in data collection, data interpretation, and reviewing the manuscript. DS was involved in data collection and contributed to study design, data analysis, data interpretation, and reviewing the manuscript. SF was involved in data collection and contributed to review of manuscript drafts. VM was involved in data collection and contributed to review of manuscript drafts. FL and RW contributed to study design, data analysis, data interpretation, and reviewing the manuscript. ML contributed to data analysis, data interpretation, and reviewing the manuscript. LC was involved in data collection, contributed to data interpretation, reviewed the manuscript, and participated as a co-investigator in the PCR.
: The study was approved by the ethics committees of every country that participated. The study was conducted in accordance with the Declaration of Helsinki.
: All patients provided written informed consent.
: Not applicable.
: Not applicable.